| The pharmacokinetics and the pharmacodynamics of cannabinoids CJ Lucas, P Galettis, J Schneider British journal of clinical pharmacology 84 (11), 2477-2482, 2018 | 646 | 2018 |
| Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: selective targeting to diseased versus healthy tissue S Hua, E Marks, JJ Schneider, S Keely Nanomedicine: nanotechnology, biology and medicine 11 (5), 1117-1132, 2015 | 520 | 2015 |
| Ivacaftor treatment of cystic fibrosis in children aged 12 to< 24 months and with a CFTR gating mutation (ARRIVAL): a phase 3 single-arm study M Rosenfeld, CE Wainwright, M Higgins, LT Wang, C McKee, D Campbell, ... The lancet respiratory medicine 6 (7), 545-553, 2018 | 233 | 2018 |
| The syringe driver: continuous subcutaneous infusions in palliative care A Dickman, J Schneider Oxford University Press, 2016 | 166 | 2016 |
| Oral antidiabetic combination therapy with sulphonylureas and metformin. E Haupt, B Knick, T Koschinsky, H Liebermeister, J Schneider, H Hirche Diabete & metabolisme 17 (1 Pt 2), 224-231, 1991 | 162 | 1991 |
| Cannabis contaminants: sources, distribution, human toxicity and pharmacologic effects LM Dryburgh, NS Bolan, CPL Grof, P Galettis, J Schneider, CJ Lucas, ... British journal of clinical pharmacology 84 (11), 2468-2476, 2018 | 138 | 2018 |
| Use of high performance liquid chromatography to measure tetrodotoxin in serum and urine of poisoned patients MA O'leary, JJ Schneider, GK Isbister Toxicon 44 (5), 549-553, 2004 | 115 | 2004 |
| Targeting peripheral opioid receptors to promote analgesic and anti-inflammatory actions KS Iwaszkiewicz, JJ Schneider, S Hua Frontiers in pharmacology 4, 132, 2013 | 110 | 2013 |
| Pharmacokinetics in neonatal prescribing: evidence base, paradigms and the future K O'Hara, IMR Wright, JJ Schneider, AL Jones, JH Martin British journal of clinical pharmacology 80 (6), 1281-1288, 2015 | 81 | 2015 |
| Can hemp help? Low-THC cannabis and non-THC cannabinoids for the treatment of cancer F Afrin, M Chi, AL Eamens, RJ Duchatel, AM Douglas, J Schneider, ... Cancers 12 (4), 1033, 2020 | 55 | 2020 |
| Current trends and opportunities for competency assessment in pharmacy education–a literature review H Croft, C Gilligan, R Rasiah, T Levett-Jones, J Schneider Pharmacy 7 (2), 67, 2019 | 54 | 2019 |
| Enzyme immunoassays in brown snake (Pseudonaja spp.) envenoming: detecting venom, antivenom and venom–antivenom complexes MA O’Leary, GK Isbister, JJ Schneider, SGA Brown, BJ Currie Toxicon 48 (1), 4-11, 2006 | 54 | 2006 |
| Pharmacokinetics and efficacy of rectal versus oral sustained-release morphine in cancer patients TJ Wilkinson, BA Robinson, EJ Begg, SB Duffull, PJ Ravenscroft, ... Cancer chemotherapy and pharmacology 31, 251-254, 1992 | 51 | 1992 |
| Survey of diabetes risk assessment tools: concepts, structure and performance T Thoopputra, D Newby, J Schneider, SC Li Diabetes/metabolism research and reviews 28 (6), 485-498, 2012 | 50 | 2012 |
| An examination of the cardiovascular effects of an ‘Irukandji’jellyfish, Alatina nr mordens KL Winter, GK Isbister, JJ Schneider, N Konstantakopoulos, JE Seymour, ... Toxicology Letters 179 (3), 118-123, 2008 | 48 | 2008 |
| Efficacy of antivenom against the procoagulant effect of Australian brown snake (Pseudonaja sp.) venom: in vivo and in vitro studies GK Isbister, MA O’Leary, JJ Schneider, SGA Brown, BJ Currie, ... Toxicon 49 (1), 57-67, 2007 | 48 | 2007 |
| Exogenous cannabinoid efficacy: merely a pharmacokinetic interaction? JH Martin, J Schneider, CJ Lucas, P Galettis Clinical pharmacokinetics 57, 539-545, 2018 | 45 | 2018 |
| Current and potential roles in sports pharmacy: a systematic review AD Hooper, JM Cooper, J Schneider, T Kairuz Pharmacy 7 (1), 29, 2019 | 44 | 2019 |
| Thinking in pharmacy practice: a study of community pharmacists’ clinical reasoning in medication supply using the think-aloud method H Croft, C Gilligan, R Rasiah, T Levett-Jones, J Schneider Pharmacy 6 (1), 1, 2017 | 41 | 2017 |
| Effects of xanthine oxidase inhibition with febuxostat on the development of nephropathy in experimental type 2 diabetes R Komers, B Xu, J Schneider, TT Oyama British journal of pharmacology 173 (17), 2573-2588, 2016 | 41 | 2016 |
